Skip to main content

ACE/ARB Therapy at Discharge for ICD implant patients with Left Ventricular Systolic Dysfunction

CBE ID
1522
1.4 Project
Cardiovascular
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Cycle / Most Recent Endorsement Activity
Full Year 2015
Is Under Review
No
1.3 Measure Description

Proportion of ICD implant patients with a diagnosis of LVSD who are prescribed ACE-I or ARB therapy at discharge.

    • 1.14 Numerator

      Count of patients with ACE-I or ARB therapy prescribed at discharge.

    • 1.15 Denominator

      1) Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ACE inhibitors who do not have a contraindication to ACE inhibitors documented
      AND
      2)Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ARB therapy who do not have a contraindication to ARB therapy documented

    • Exclusions

      Discharge status of expired
      Contraindicated or blinded to both ACE inhibitors and ARB therapy

    • Most Recent Endorsement Activity - OLD
      Measure Retired and Endorsement Removed Cardiovascular Project 2015-2016
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      American College of Cardiology
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      © 2010 American College of Cardiology Foundation All Rights Reserved